IL18R1 and infection: Relative to milder infections, IL18R1 expression was elevated in patients with moderate to severe (P = 0.029) and life-threatening respiratory dysfunction (P = 0.0012) as well as those with MIS-C (P < 0.0001), a post-infection severe hyperinflammatory complication linked to prior SARS-CoV-2 infection.